BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4348973)

  • 21. Enhancement of the mixed lymphocyte response in the mouse by addition of thymocytes.
    Jacobsson H; Blomgren H
    Cell Immunol; 1974 Feb; 10(2):294-309. PubMed ID: 4281720
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of genetically defined nude mice in the study of the mixed leukocyte reaction.
    Croy BA; Osoba D
    J Immunol; 1974 Nov; 113(5):1626-34. PubMed ID: 4278870
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the syngeneic mixed lymphocyte reaction. II. Decline in he syngeneic mixed lymphocyte reaction with age.
    Gutowski JK; Weksler ME
    Immunology; 1982 Aug; 46(4):801-8. PubMed ID: 6213555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blastogenic response of lymphoid cells to tumor cells or tumor membrane extracts in vitro.
    Poon SP; Cauchi MN
    Cancer Res; 1973 Nov; 33(11):2677-82. PubMed ID: 4270637
    [No Abstract]   [Full Text] [Related]  

  • 25. Age-related decline in response to phytohemagglutinin and pokeweed mitogen by spleen cells from hamsters and a long-lived mouse strain.
    Mathies M; Lipps L; Smith GS; Walford RL
    J Gerontol; 1973 Oct; 28(4):425-30. PubMed ID: 4542835
    [No Abstract]   [Full Text] [Related]  

  • 26. Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F 1 hybrids.
    Smith GS; Walford RL; Mickey MR
    J Natl Cancer Inst; 1973 May; 50(5):1195-213. PubMed ID: 4351393
    [No Abstract]   [Full Text] [Related]  

  • 27. Cross-reactivity exists between Mlsa and Mlsd lymphocyte-activating determinants as demonstrated by the negative clonal selection of responder cells in a mixed lymphocyte reaction.
    Ryan JJ; Ahmed A; Kind P; Sell KW
    Transplant Proc; 1979 Jun; 11(2):1377-8. PubMed ID: 157575
    [No Abstract]   [Full Text] [Related]  

  • 28. Production of colony-stimulating factor in mitogen-stimulated lymphocyte cultures.
    Parker JW; Metcalf D
    J Immunol; 1974 Feb; 112(2):502-10. PubMed ID: 4591973
    [No Abstract]   [Full Text] [Related]  

  • 29. Mixed leukocyte culture reactivity and chronic graft-versus-host reactions (secondary disease) between allogeneic H-2k mouse strains.
    Rodey GE; Bortin MM; Bach FH; Rimm AA
    Transplantation; 1974 Jan; 17(1):84-8. PubMed ID: 4148890
    [No Abstract]   [Full Text] [Related]  

  • 30. Spontaneous hepatocellular neoplasms and hepatic hemangiosarcomas in several strains of mice.
    Frith CH; Wiley L
    Lab Anim Sci; 1982 Apr; 32(2):157-62. PubMed ID: 6281574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes of MLC reactivity in lymphoid organs after injection of mice with H-2 disparate cells.
    Jacobsson H; Lilliehöök B; Blomgren H
    Cell Immunol; 1975 May; 17(1):259-67. PubMed ID: 123829
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum factors in lymphocyte proliferation. I. The requirement for serum in mixed lymphocyte reactions.
    Huber SA; Berke G; Amos DB
    Cell Immunol; 1973 Dec; 9(3):405-11. PubMed ID: 4271342
    [No Abstract]   [Full Text] [Related]  

  • 33. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    Ryan JJ; Mond JJ; Finkelman FD; Scher I
    J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The control exerted by thymic hormone (THF) on cellular cAMP levels and immune reactivity of spleen cells in the MLC assay.
    Kook AI; Trinin N
    J Immunol; 1975 Jul; 115(1):8-14. PubMed ID: 168258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of mouse thymocytes by syngeneic spleen cells in mixed lymphocyte reactions.
    von Boehmer H; Byrd WJ
    Adv Exp Med Biol; 1973; 29(0):217-23. PubMed ID: 4277666
    [No Abstract]   [Full Text] [Related]  

  • 36. Correlation between morphological blastformation rate and functional 3H-thymidine uptake in mixed lymphocyte culture in the presence of PHA.
    Orita K; Miwa H; Kaneda S
    Acta Med Okayama; 1974 Aug; 28(4):253-7. PubMed ID: 4280235
    [No Abstract]   [Full Text] [Related]  

  • 37. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strong stimulation of CBA lymphocytes in the mixed lymphocyte interaction with cells from the H-2-indentical strain C3H.
    Lilliehöök B; Blomgren H
    Scand J Immunol; 1974; 3(5):627-35. PubMed ID: 4138633
    [No Abstract]   [Full Text] [Related]  

  • 39. Absorption of normal lymphocytes on allogeneic spleen monolayers: depletion of alloreactivity is due to inhibition of CTL induction by released monolayer cells.
    Kelso A
    J Immunol; 1981 Oct; 127(4):1563-9. PubMed ID: 6456308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Specificity of cell-mediated cytotoxicity. II. Cytotoxic lymphocytes after in vitro allogeneic sensitization in the H-2 system].
    Schulze HA; Brock J
    Allerg Immunol (Leipz); 1983; 29(2):100-7. PubMed ID: 6224410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.